Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/1991
11/06/1991EP0455159A1 4'-Demethylepipodophyllotoxin glycosides
11/06/1991EP0455013A1 Ammoniumsalts of N(5)-methyl-5,6,7,8-tetrahydrofolic acid
11/06/1991EP0454781A1 Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof
11/06/1991EP0454728A1 Fluorinated flavone acetic acid.
11/06/1991CN1055879A Antibody conjugates for treatment of neoplastic disease
11/05/1991CA1291710C Tetrapyrrole therapeutic agents
10/1991
10/31/1991WO1991016629A1 Ctaa 28a32, the antigen recognized by mca 28a32
10/31/1991WO1991016354A1 Processes and intermediates for synthetic antibody derivatives
10/31/1991WO1991016347A1 Composition for macrophage activation
10/31/1991WO1991016340A1 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase
10/31/1991WO1991016324A1 Novel cc-1065 analogs
10/31/1991WO1991016315A1 5-benzyl barbiturate derivatives
10/31/1991WO1991016302A1 Phenolic amine depigmenting and antimelanoma agents
10/31/1991WO1991016071A1 Antibody conjugates for treatment of neoplastic disease
10/31/1991WO1991013055A3 New aryl- and heteroarylethenylene derivatives and process for their preparation
10/31/1991CA2079601A1 Ctaa 28a32, the antigen recognized by mca 28a32
10/30/1991EP0454587A1 Heterocyclic derivatives: 2-styryl-4H-1-benzopyran-4-ons, process for their preparation and pharmaceutical compositions containing them
10/30/1991EP0454494A2 Calicheamicinone, derivatives and analogs thereof and methods of making the same
10/30/1991EP0454427A1 Antiretroviral bases
10/30/1991EP0454146A1 Cytotoxic bicyclo[7.3.1] tridec-4-ene-2,6-diyne compounds and process for the preparation thereof
10/30/1991EP0454127A1 Hardening agent for affected tissues of digestive system
10/30/1991EP0454044A2 Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance
10/30/1991EP0453560A1 Localization and characterization of the wilms's tumor gene
10/30/1991EP0453482A1 Biologically active synthetic thyrotropin and cloned gene for producing same
10/30/1991EP0438519A4 Therapeutic peptides
10/30/1991EP0358719B1 Liposome compositions of anthracycline derivatives
10/30/1991CN1055819A Pharmaceutical containing episialo complex carbohydrate
10/30/1991CN1055740A Difluoroglutamic acid conjugates with folates and anti-folates for treatment of neoplastic disease
10/30/1991CN1055739A Hemihydrate
10/30/1991CN1055732A Novel alpha-mannosidase and fucosidase inhibitors
10/29/1991US5061800 Camptothecin derivatives
10/29/1991US5061705 Skin disorders
10/29/1991US5061699 Compounds effective in inducing cell differentiation and process for preparing same
10/28/1991CA2041163A1 Heterocyclic derivatives : 2-styryl-4h-1-benzopyran-4-ones; process for preparing the same and pharmaceutical compositions containing them
10/28/1991CA2040855A1 Cytotoxic bicyclo¬7.3.1| tridec-4-ene-2,6-diyne compounds and process for the preparation thereof
10/28/1991CA2039789A1 Calicheamicinone, derivatives and analogs thereof and methods of making the same
10/26/1991WO1991016049A1 Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof
10/26/1991CA2081346A1 Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof
10/23/1991EP0452660A2 L-glutamic acid derivatives
10/23/1991EP0452598A1 Use of a polypeptide having interleukin-2 activity for the preparation of a pharmaceutical composition for the treatment of simple pleura cancer
10/23/1991EP0452447A1 Reduced irreversible bombesin antagonists
10/23/1991EP0452391A1 A polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide.
10/23/1991EP0452315A1 Method of treating myeloid leukemias
10/23/1991EP0418230A4 Method for potentiating and inhibiting insulin-like growth factor activity
10/22/1991US5059699 Water soluble derivatives of taxol
10/22/1991US5059619 Stable freeze-dried polyhematoporphyrin ether/ester
10/22/1991US5059412 Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
10/22/1991CA1291293C Substituted 7-oxomitosanes
10/22/1991CA1291163C Benzenesulfonamido derivatives
10/22/1991CA1291122C 3'-hydroxy-4'-epi-amino anthracyclines
10/22/1991CA1291054C Antitumor antibiotics (ll-e33288 complex)
10/22/1991CA1291037C Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
10/21/1991CA2040773A1 Naphthalene derivatives
10/19/1991WO1991016078A1 Conjugate compounds containing aza-macrocycles, and processes for their preparation
10/19/1991CA2058985A1 Conjugate compounds containing aza-macrocycles, and processes for their preparation
10/19/1991CA2037015A1 L-glutamic acid derivatives
10/17/1991WO1991016305A1 Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase
10/17/1991WO1991015580A1 Gene therapy for cell proliferative diseases
10/17/1991WO1991015485A1 Novel pyridine esters
10/17/1991WO1991015475A1 Novel vitamin d analogues
10/17/1991WO1991015227A1 Method and compositions for treating injury
10/17/1991WO1991015224A1 Inhibition of disease associated with immunodeficiency virus infection
10/17/1991WO1991006658A3 Infective protein delivery system
10/17/1991WO1991000916A3 Receptors for fibroblast growth factors
10/17/1991CA2080582A1 Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase
10/17/1991CA2079903A1 Gene therapy for cell proliferative diseases
10/17/1991CA2018630A1 Use of a polypeptide having human interleukine 2 activity to prepare a pharmaceutical compound for the treatment of primary cancer of the plevra
10/16/1991EP0451972A1 Utilization of enzymes
10/16/1991EP0451957A2 Cyclohexapeptide compound
10/16/1991EP0451880A2 An ex vivo tissue perfusion composition and the use thereof
10/16/1991EP0451836A2 Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
10/16/1991EP0451835A1 Intermediates for difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
10/16/1991EP0451834A2 Alpha-mannosidase and fucosidase inhibitors
10/16/1991EP0451753A1 In the ethylenic moiety substituted phenylalkylethylenediamine-platinum (II or IV) derivatives and phenylalkyl-ethylenediamines
10/16/1991EP0451612A1 Anti-oncostatin M monoclonal antibodies
10/16/1991EP0451550A2 Seroreactive epitopes of human Papillomavirus (HPV) 16 proteins
10/16/1991EP0451299A1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier
10/16/1991EP0451211A1 Cloning and production of polypeptide analogs of human fibronectin and method of using such polypeptide analogs
10/16/1991EP0423193A4 A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human
10/16/1991EP0210269B1 X-ray-emitting interstitial implants
10/16/1991CN1055389A Novel proteins with oncostatin m activity and process for their preparation
10/15/1991US5057530 Glycerol derivatives
10/15/1991US5057304 Active compounds for use in the treatment of tumors
10/15/1991CA1290753C Tetrapyrrole therapeutic agents
10/15/1991CA1290688C Use of interleukin-1 to induce development of multipotent hemopoietic cell populations
10/14/1991CA2080002A1 Composition for macrophage activation
10/13/1991CA2040397A1 Ammonium salts of n5-methyl-5,6,7,8-tetrahydrofolic acid
10/13/1991CA2040059A1 Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
10/11/1991WO1991015507A1 Phosphonopeptides with collagenase inhibiting activity
10/11/1991WO1991015484A1 Pyridines as medicaments
10/11/1991CA2080227A1 Phosphonopeptides with collagenase inhibiting activity
10/11/1991CA2080127A1 Pyridines as medicaments
10/11/1991CA2040123A1 Ethylene-substituted phenylalkylethylenediamine-platinum (ii or iv) derivatives and phenylalkylethylenediamines
10/10/1991WO1991015499A1 2'-o-alkyl nucleotides and polymers containing them
10/10/1991DE4037363A1 New 2-O-alkyl nucleotide(s) and polymers contg. them - for nuclease-resistant anti-sense probes and to treat viral infection including herpes influenza and AIDS and cancer
10/09/1991EP0450792A2 Glomerellan as an immunostimulant and/or an anti-tumor agent
10/09/1991EP0450480A2 Somatostatin Analogues
10/09/1991EP0450472A1 Monoclonal antibodies that inhibit growth of kaposi's sarcoma
10/09/1991EP0450461A2 LHRH Analogs
10/09/1991EP0450327A1 Biosynthesis of rebeccamycin analogs by tryptophan analogs feeding
1 ... 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 ... 2211